Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease

BACKGROUND: Treatment with angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is used to reduce proteinuria and retard the progression of chronic kidney disease (CKD). However, resolution of proteinuria may be incomplete with these therapies and the addition of a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cochrane Database Syst Rev
Prif Awduron: Chung, Edmund YM, Ruospo, Marinella, Natale, Patrizia, Bolignano, Davide, Navaneethan, Sankar D, Palmer, Suetonia C, Strippoli, Giovanni FM
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Ltd 2020
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094274/
https://ncbi.nlm.nih.gov/pubmed/33107592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007004.pub4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg